The company will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHIO:
- Phio Pharmaceuticals: Promising Clinical Results and Strong Financial Position Justify Buy Rating
- Phio Pharmaceuticals Exercises Warrants for $13.4 Million
- 3 Penny Stocks to Watch Now, 11/4/25
- PHIO Upcoming Earnings Report: What to Expect?
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!